1',3'-dimethylspiro[1,3,4,6,7,12b-hexahydro-[1]benzofuro[2,3-a]quinolizine-2,4'-1,3-diazinane]-2'-one
-
![1',3'-dimethylspiro[1,3,4,6,7,12b-hexahydro-[1]benzofuro[2,3-a]quinolizine-2,4'-1,3-diazinane]-2'-one structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220811/2766bc85b0f0429fb019c115ad05304e.png "1',3'-dimethylspiro[1,3,4,6,7,12b-hexahydro-[1]benzofuro[2,3-a]quinolizine-2,4'-1,3-diazinane]-2'-one")
1',3'-dimethylspiro[1,3,4,6,7,12b-hexahydro-[1]benzofuro[2,3-a]quinolizine-2,4'-1,3-diazinane]-2'-one
structure -
-
CAS No:
111466-41-2
-
Formula:
C20H25N3O2
-
Chemical Name:
1',3'-dimethylspiro[1,3,4,6,7,12b-hexahydro-[1]benzofuro[2,3-a]quinolizine-2,4'-1,3-diazinane]-2'-one
-
Synonyms:
1',3'-dimethylspiro(1,3,4,5',6,6',7,12b-octahydro-2H-benzo(b)furo(2,3-a)quinolizine)-2,4'-pyrimidin-2'-one;L 657,743;L 657743;L-657,743;L-657,743-002W;MK 912;MK-912;MK-912;Lopac0_000760;CHEMBL1256985;BDBM81811;111466-41-2;PDSP1_001652;PDSP2_001636;CAS_123679;CCG-204845;NSC_123679;SDCCGSBI-0050738.P002;NCGC00015699-02;NCGC00015699-03;NCGC00015699-05;NCGC00162243-01;1',3'-dimethylspiro[1,3,4,6,7,12b-hexahydro-[1]benzofuro[2,3-a]quinolizine-2,4'-1,3-diazinane]-2'-one;L023963;Spiro[2H-benzofuro[2,3-a]quinolizine-2,4'(1'H)-pyrimidin]-2'(3'H)-one,1,3,4,5',6,6',7,12b-octahydro-1',3'-dimethyl-, (2S,12bS)-
-
CAS No:
1',3'-dimethylspiro[1,3,4,6,7,12b-hexahydro-[1]benzofuro[2,3-a]quinolizine-2,4'-1,3-diazinane]-2'-one Basic Attributes
339.4 g/mol
339.19467705 g/mol
Drug Information
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
1',3'-dimethylspiro(1,3,4,5',6,6',7,12b-octahydro-2H-benzo(b)furo(2,3-a)quinolizine)-2,4'-pyrimidin-2'-one
Request for Quotation